Health News Releases

  • Today May 21
August 21, 2015 09:45
Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events
Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME®. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardi
August 19, 2015 17:20
CHMP recommends label update for Giotrif® with addition of data demonstrating overall survival benefit for patients with EGFR mutation-positive lung cancer
Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to the European l
August 17, 2015 17:05
New data show Spiolto Respimat provides meaningful quality of life improvements in COPD
Boehringer Ingelheim today announced the publication of new data from the Phase IIIb OTEMTO® 1&2 trials (NCT01964352 (https://goo.gl/SvaXth)/NCT02006732 (https://goo.gl/F7UiIQ)), which show Spiolto® R
August 06, 2015 23:00
Chiltern Announces Agreement to Acquire Theorem Clinical Research
Chiltern (www.chiltern.com), a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research (www.theoremclinical.com), another
August 05, 2015 17:15
The Patient Safety Movement Foundation Names the Top 3 Healthcare Institutions that Demonstrated the Most Lives Saved
The Patient Safety Movement Foundation (http://patientsafetymovement.org) announced the winners of the top three healthcare institutions that demonstrated the most lives saved through their commitment
July 29, 2015 12:10
Boehringer Ingelheim enters into an exclusive license agreement with Hanmi Pharmaceutical to develop 3rd generation EGFR targeted therapy in lung cancer
Boehringer Ingelheim and Hanmi Pharmaceutical Co. Ltd today announced an exclusive license and collaboration agreement for the development and global commercialisation rights, except South Korea, Chin
July 28, 2015 11:30
European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted an accelerated asses
July 27, 2015 13:50
Panasonic Showcases Its Innovative Medical IT Solutions Brought to Life by Medicom @ International Modern Hospital Show 2015
Panasonic Healthcare Co., Ltd. (hereafter “Panasonic”) took part in the International Modern Hospital Show 2015, which was held from July 15 to 17, 2015 at the Tokyo Big Sight. Under the theme, “A new
July 24, 2015 10:55
Panasonic Autonomous Delivery Robots - HOSPI - Aid Hospital Operations at Changi General Hospital in Singapore
In line with the country’s goal of becoming a Smart Nation, Panasonic System Solutions Asia Pacific (PSSAP) and Changi General Hospital (CGH) are implementing assistive robotics technology to improve
July 23, 2015 15:55
Patient Safety Movement Foundation Announces the 4th Annual Patient Safety, Science & Technology Summit
The Patient Safety Movement Foundation (http://patientsafetymovement.org) announces the 4th annual Patient Safety, Science & Technology Summit (http://goo.gl/GVIFrr) on Jan. 22-23, 2016 at the Laguna
July 20, 2015 10:45
Patient Safety Movement Foundation’s Midyear Planning Meeting Co-convened with the Chapman University School of Pharmacy
The Patient Safety Movement Foundation (http://patientsafetymovement.org) is co-convening with Chapman University School of Pharmacy for their Midyear Planning Meeting on July 29, 2015 on Chapman’s ma
July 17, 2015 10:20
Efficacy Results of Otsuka’s Delamanid (Deltyba™) for Extensively Drug-Resistant Tuberculosis (XDR-TB) Published in the New England Journal of Medicine
Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that data from a post-hoc subset analysis of its Phase IIb clinical trial suggesting potential efficacy of delamanid for the treatment of exten
July 16, 2015 11:00
Boehringer Ingelheim Welcomes the Inclusion of OFEV® (nintedanib*) in the Updated International Treatment Guidelines for Idiopathic Pulmonary Fibrosis (IPF)
Boehringer Ingelheim welcomes the international evidence-based 2015 ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis - An Update of the 2011 Guideline which sug
July 15, 2015 17:30
Takeda Submits New Drug Application for Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that a New Drug Application (NDA) has been submitted to the United States (U.S.) Food and Drug Administration (FDA) for ixazomib, an i
July 14, 2015 13:10
Masimo Renews its $1,000,000 Performance Guarantee that Masimo SET® Technology Will Outperform All Nellcor™ Pulse Oximeters
Masimo (NASDAQ: MASI), the inventor of measure-through motion and low perfusion pulse oximetry, today renewed its $1,000,000 (USD) performance guarantee that Masimo SET® Pulse Oximetry will outperform
July 07, 2015 09:15
Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib)
Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib) in patients with previously treated advanced squamo
July 03, 2015 11:45
Quintiles and Quest Diagnostics Launch Q2 Solutions
Quintiles (www.quintiles.com) and Quest Diagnostics (http://goo.gl/NbIXp) today announced the launch of Q2 Solutions (www.q2labsolutions.com), their new combined clinical trials laboratory services or
July 02, 2015 15:25
New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries
Boehringer Ingelheim today announced regulatory authority approvals for Spiolto® Respimat® (tiotropium/olodaterol) in first European countries†. Spiolto® Respimat® is a once-daily maintenance treatmen
July 01, 2015 11:40
Turkey’s Leading University Hospital Adopts Masimo SpHb for Continuous Noninvasive Haemoglobin Monitoring
Masimo (www.masimo.co.uk) (NASDAQ: MASI) announced today that Turgut Ozal Medical Centre Liver Hospital (http://totm.inonu.edu.tr/index.php) in Malatya, Turkey, has installed Masimo’s noninvasive, con
June 30, 2015 14:00
Cranberry Juice May Help Protect Against Heart Disease and Diabetes Risk Factors
A new study[1] reveals that drinking low-calorie cranberry juice cocktail may help lower the risk of chronic diseases that rank among the leading causes of death worldwide, including heart disease, di
June 25, 2015 10:15
Estima Pharma Solutions LLP Wins CQE Award for Compliance on QC100 Total Quality Management Model Criteria for 2015
Recognized for Commitment to Quality, Excellence, Leadership, Technology and Innovation, Estima Pharma Solutions LLP, India, was presented the CQE Century International Quality ERA Award, for complian
June 25, 2015 02:00
Morinaga Milk Industry: Probiotic Supplementation Causes Fat Loss in Overweight Adults
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the second largest dairy product company in Japan, confirmed that its new probiotic ingredient, Bifidobacterium breve B-3, caused a significant reduction
June 24, 2015 10:40
Masimo Receives CE Mark for MightySat Rx Pulse Oximeter
Masimo (http://masimo.co.uk) (NASDAQ: MASI) today announced the CE Mark and full market release of MightySat™ Rx fingertip pulse oximeter for clinical use in CE countries, offering the same Masimo SET
June 23, 2015 10:10
Idarucizumab* reverses the anticoagulant effect of dabigatran within minutes in patient study
Results from an interim analysis of the Phase III RE-VERSE AD™ patient study demonstrate that 5 g of idarucizumab* immediately reversed the anticoagulant effect of dabigatran (Pradaxa®) in patients re
June 21, 2015 09:00
Dr. Seo Hyo-seok Gave Lecture on Unique Concepts of Korean Medicine at 2015 World Conference of Science Journalists
Dr. Seo Hyo-seok participated in the ‘2015 World Conference of Science Journalists’ held in COEX, Samsung-dong, Seoul, Korea from the 8th to the 12th in his capacity as a sponsor and explained the con
25 per page50 per page75 per page100 per page